Below is a list of titles that have been registered, but not yet published as protocols.
- Circadian hydrocortisone replacement regimens for congenital adrenal hyperplasia
- Combined large neutral amino acid supplementation for phenylketonuria
- Desmopressin (DDAVP) for for preventing and treating bleeding in people with mild and moderate haemophilia
- Dietary interventions for maple syrup urine disease
- Enzyme replacement therapy for late onset Pompe's disease
- Enzyme replacement therapy for mucopolysaccharidosis type IV (Morquio syndrome)
- Growth hormone therapy for people with thalassaemia
- Hydroxyurea for beta-thalassemia major
- Inhaled muco-active agents for cystic fibrosis: an overview of Cochrane systematic reviews
- Interventions for chronic kidney disease in people with sickle cell disease
- Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
- Interventions for managing infertility in people with beta-thalassaemia major or intermedia
- Interventions for promoting participation in shared decision making for children with cystic fibrosis
- Non-CFTR mediated chloride secretagogues for cystic fibrosis lung disease
- Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of systematic reviews
- Sweat test for the diagnosis of cystic fibrosis in all age groups (DTA)
- Therapies to prevent recurrence of Pseudomonas aeruginosa in people with cystic fibrosis
- Treatment of dental complications in thalassaemia
- Transcutaneous electrical nerve stimulation (TENS ) and biofeedback as complementary and alternative therapies for managing pain in sickle cell disease